CN1206538C - 用于消除含有脂蛋白颗粒的脂血样品浑浊现象的试剂 - Google Patents

用于消除含有脂蛋白颗粒的脂血样品浑浊现象的试剂 Download PDF

Info

Publication number
CN1206538C
CN1206538C CNB021017824A CN02101782A CN1206538C CN 1206538 C CN1206538 C CN 1206538C CN B021017824 A CNB021017824 A CN B021017824A CN 02101782 A CN02101782 A CN 02101782A CN 1206538 C CN1206538 C CN 1206538C
Authority
CN
China
Prior art keywords
reagent
sample
ionics
polyoxyethylene
clarification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB021017824A
Other languages
English (en)
Chinese (zh)
Other versions
CN1372144A (zh
Inventor
G·冈泽
T·拉金
A·普福茨纳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Olympus Life Science Research Europa GmbH
Beckman Coulter Biomedical Ltd
Original Assignee
OLINPIS DIAGNOSIS AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OLINPIS DIAGNOSIS AG filed Critical OLINPIS DIAGNOSIS AG
Publication of CN1372144A publication Critical patent/CN1372144A/zh
Application granted granted Critical
Publication of CN1206538C publication Critical patent/CN1206538C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
CNB021017824A 2001-02-19 2002-01-18 用于消除含有脂蛋白颗粒的脂血样品浑浊现象的试剂 Expired - Fee Related CN1206538C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01103991A EP1233269B1 (en) 2001-02-19 2001-02-19 Agent for the removal of turbidity in biological samples
EP01103991.4 2001-02-19

Publications (2)

Publication Number Publication Date
CN1372144A CN1372144A (zh) 2002-10-02
CN1206538C true CN1206538C (zh) 2005-06-15

Family

ID=8176537

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB021017824A Expired - Fee Related CN1206538C (zh) 2001-02-19 2002-01-18 用于消除含有脂蛋白颗粒的脂血样品浑浊现象的试剂

Country Status (7)

Country Link
US (1) US6680201B2 (enExample)
EP (1) EP1233269B1 (enExample)
JP (1) JP3908556B2 (enExample)
CN (1) CN1206538C (enExample)
AT (1) ATE254767T1 (enExample)
CA (1) CA2370660C (enExample)
DE (1) DE60101254T2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101223448B (zh) * 2005-05-20 2012-01-18 健泰科生物技术公司 来自自身免疫病受试者的生物学样品的预处理
WO2007056426A2 (en) * 2005-11-08 2007-05-18 United States Postal Service Methods and systems for providing scanned mail delivery channel and automatic payment of reply mail
US8597513B2 (en) * 2009-02-06 2013-12-03 Ut-Battelle, Llc Microbial fuel cell treatment of fuel process wastewater
CN101957363A (zh) * 2010-09-13 2011-01-26 南京卡博生物科技有限公司 胶乳免疫比浊检测用样本处理液
CN105067815A (zh) * 2015-09-16 2015-11-18 浙江凯成生物科技有限公司 一种测定人血清中胃蛋白酶原i/ii含量的试剂盒
CN111157712A (zh) * 2018-11-07 2020-05-15 深圳迈瑞生物医疗电子股份有限公司 可抗脂血干扰的血液样本检测试剂盒及方法
CN112834758B (zh) * 2021-01-07 2023-06-16 北京九强生物技术股份有限公司 B因子的检测试剂盒

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853465A (en) * 1972-06-09 1974-12-10 Technicon Instr Turbidity reduction in serum and plasma samples using polyoxyethylated lauric acid compounds
US4184921A (en) * 1976-03-25 1980-01-22 Boehringer Mannheim Gmbh Process and reagent for determining cholesterol
DE2724757C2 (de) * 1977-06-01 1979-08-23 Boehringer Mannheim Gmbh, 6800 Mannheim Mittel zur Beseitigung von Trübungen in Serum und Verfahren zu seiner Herstellung
DE2816229C2 (de) * 1978-04-14 1983-11-10 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und Mittel zur Beseitigung von Trübungen
US4503146A (en) * 1980-10-01 1985-03-05 Technicon Instruments Corporation Method for eliminating turbidity in a biological fluid and reagent therefor
DE3323949A1 (de) * 1983-07-02 1985-01-03 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und mittel zur raschen und vollstaendigen beseitigung einer truebung in einer biologischen fluessigkeit
DE3329952A1 (de) * 1983-08-19 1985-02-28 Behringwerke Ag, 3550 Marburg Verfahren zur verringerung einer truebung in kontrollseren
US5310679A (en) * 1985-05-13 1994-05-10 Artiss Joseph D Composition for reducing turbidity in samples of biological fluids
US4626511A (en) * 1985-05-13 1986-12-02 Wayne State University Composition for reducing turbidity in samples of biological fluids
DE3920364A1 (de) * 1989-06-22 1991-01-10 Technicon Gmbh Verfahren und reagenz zur verhinderung von truebungen
DE4018502A1 (de) * 1990-06-09 1991-12-12 Merck Patent Gmbh Verfahren und mittel zur beseitigung von truebungen in biologischen fluessigkeiten
JPH10213582A (ja) * 1997-01-30 1998-08-11 Eiken Chem Co Ltd 生体試料の濁りの除去方法

Also Published As

Publication number Publication date
CN1372144A (zh) 2002-10-02
ATE254767T1 (de) 2003-12-15
CA2370660A1 (en) 2002-08-19
JP3908556B2 (ja) 2007-04-25
JP2002277470A (ja) 2002-09-25
US6680201B2 (en) 2004-01-20
DE60101254D1 (de) 2003-12-24
US20020151074A1 (en) 2002-10-17
CA2370660C (en) 2013-05-28
EP1233269B1 (en) 2003-11-19
EP1233269A1 (en) 2002-08-21
DE60101254T2 (de) 2004-04-22

Similar Documents

Publication Publication Date Title
CA1229772A (en) Process and reagent for the complete and rapid removal of a turbidity in a biological fluid
CN1206538C (zh) 用于消除含有脂蛋白颗粒的脂血样品浑浊现象的试剂
US9046517B2 (en) Cystatin C adsorption inhibitor
WO2010001619A1 (ja) 免疫学的測定における感度増強方法又はヘモグロビンの影響回避方法
CN111896731B (zh) 一种化学发光免疫分析用清洗液
JPWO2001092885A1 (ja) 免疫学的ラテックス比濁分析方法及びその試薬
EP2554991B1 (en) Method for reducing interference by component outside latex immunoagglutination assay system
Morgan et al. Calcium determination in serum with stable alkaline Arsenazo III and triglyceride clearing
Chromy et al. Photometric determination of total protein in lipemic sera
EP0786666B1 (en) Improved assay for aminoglycoside antibiotics
US6165796A (en) Pipettable ion detector and method
CN111157712A (zh) 可抗脂血干扰的血液样本检测试剂盒及方法
Far et al. ELISA on a microchip with a photodiode for detection of amphetamine in plasma and urine
CN1926432B (zh) 免疫测定法用测定值降低抑制剂及使用其的免疫测定法
WO2010013525A1 (ja) 複合体の測定方法およびそれに用いるキット
CN1556408A (zh) 检测载脂蛋白m的免疫比浊法
WO2024190866A1 (ja) 処理方法及びキット
Fotiou Automated rate nephelometric determination of apolipoproteins AI and B in human serum by consecutive addition of antibodies
WO2025111449A1 (en) Method and reagent to clear turbidity due to elevated triglycerides in a biological specimen
JPH07181182A (ja) リポタンパク質含有試料の処理法
Artiss et al. Application of a sensitive and specific reagent for the determination of serum iron to the Bayer DAX48
WO2022154121A1 (ja) ヘプシジンの吸着抑制剤、吸着抑制方法、標準品、試薬、キットおよび測定方法
Datta et al. 3 Immunoassays for Therapeutic Drug Monitoring: Pitfalls
EP0925507B1 (en) Prevention of probe coating on automated analyzers using a non-denaturing surfactant
Datta Effect of Hemolysis, High Bilirubin, Lipemia, Paraproteins, and System Factors on Therapeutic Drug Monitoring

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: BECKMAN COULTER BIOMEDICAL CO., LTD.

Free format text: FORMER OWNER: OLYMPUS LIFE SCIENCE RESEARCH EUROPA GMBH

Effective date: 20100919

Owner name: OLYMPUS LIFE SCIENCE RESEARCH EUROPA GMBH

Free format text: FORMER OWNER: OLINPIS DIAGNOSIS AG

Effective date: 20100919

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: HAMBURG, GERMANY TO: DUBLIN, IRELAND

TR01 Transfer of patent right

Effective date of registration: 20100919

Address after: Dublin, Ireland

Patentee after: BECKMAN COULTER BIOMEDICAL LTD.

Address before: Hamburg Federal Republic of Germany

Patentee before: OLYMPUS Life Sciences exploration Europe Ltd.

Effective date of registration: 20100919

Address after: Hamburg Federal Republic of Germany

Patentee after: OLYMPUS Life Sciences exploration Europe Ltd.

Address before: Hamburg Federal Republic of Germany

Patentee before: Olympus Diagnostica GmbH

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20050615

Termination date: 20200118